Why Merck & Co. Inc. (NYSE:MRK) Stock climbed 15.82% in Last Three Months?

SVB Leerink raised the price target for the Merck & Co. Inc. (NYSE:MRK) stock to ‘an Outperform’. The rating was released on June 06, 2023, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $93. The stock was initiated by Daiwa Securities, who disclosed in a research note on December 16, 2021, to Neutral and set the price objective to $70. In their research brief published December 13, 2021, UBS analysts downgraded the Merck & Co. Inc.